Sex Differences in Age of Onset of Premature Cardiovascular Disease and Subtypes: The Coronary Artery Risk

Alexa A Freedman1, Laura A Colangelo1, Hongyan Ning1

  • 1Department of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL USA.

Insights

Men develop cardiovascular disease (CVD) earlier than women, particularly coronary heart disease (CHD). This sex gap in CVD risk emerges at age 35 and persists through midlife.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Historical data show men develop coronary heart disease (CHD) 10 years earlier than women.
  • Contemporary persistence of this sex gap in cardiovascular disease (CVD) risk is unknown, especially with changing cardiometabolic profiles.
  • Differences in stroke and heart failure incidence by sex are also not well-established.

Purpose of the Study:

  • To determine if the sex gap in premature cardiovascular disease (CVD) onset persists in a contemporary US adult cohort.
  • To compare sex differences in the incidence of specific CVD subtypes: coronary heart disease (CHD), heart failure, and stroke.
  • To identify the age at which sex differences in CVD risk begin to emerge.

Main Methods:

  • Analysis of data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, a prospective multicenter cohort.
  • Follow-up of US adults (aged 18-30 at enrollment 1985-1986) through August 2020.
  • Comparison of cumulative incidence functions for premature CVD and subtypes using Gray's test.

Main Results:

  • Men showed a significantly higher cumulative incidence of CVD, CHD, and heart failure compared to women (P<0.05).
  • No significant sex difference was observed for stroke incidence (P=0.63).
  • Men reached 5% CVD incidence 7 years earlier than women (age 50.5 vs. 57.5). CHD incidence diverged significantly, with men reaching 2% incidence 10.1 years earlier.

Conclusions:

  • Men develop cardiovascular disease (CVD) earlier than women, with the most pronounced difference seen in coronary heart disease (CHD).
  • Sex differences in CVD risk become apparent at age 35 and continue through midlife.
  • These disparities are not mitigated by accounting for overall cardiovascular health.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
426
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
368
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
684
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
559